Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1049767111 | 10497671 | 11 | F | 201402 | 20160920 | 20141006 | 20160930 | EXP | US-SANOFI-AVENTIS-2013SA050971 | AVENTIS | 54.00 | YR | A | F | Y | 51.70000 | KG | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1049767111 | 10497671 | 1 | PS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | UNKNOWN | 202992 | 14 | MG | COATED TABLET | QD | ||||||
| 1049767111 | 10497671 | 2 | SS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | UNK | 202992 | 14 | MG | COATED TABLET | QD | ||||||
| 1049767111 | 10497671 | 3 | SS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | UNK | 202992 | 14 | MG | TABLET | QD | ||||||
| 1049767111 | 10497671 | 4 | SS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | UNK | 202992 | 14 | MG | TABLET | QD | ||||||
| 1049767111 | 10497671 | 5 | SS | AUBAGIO | TERIFLUNOMIDE | 1 | Oral | UNK | 202992 | 14 | MG | TABLET | QD | ||||||
| 1049767111 | 10497671 | 6 | C | LYRICA | PREGABALIN | 1 | 0 | 100 | MG | BID | |||||||||
| 1049767111 | 10497671 | 7 | C | RITALIN | METHYLPHENIDATE HYDROCHLORIDE | 1 | 0 | 10 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1049767111 | 10497671 | 1 | Multiple sclerosis |
| 1049767111 | 10497671 | 2 | Multiple sclerosis |
| 1049767111 | 10497671 | 3 | Multiple sclerosis |
| 1049767111 | 10497671 | 4 | Multiple sclerosis |
| 1049767111 | 10497671 | 5 | Multiple sclerosis |
| 1049767111 | 10497671 | 6 | Neuralgia |
| 1049767111 | 10497671 | 7 | Fatigue |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1049767111 | 10497671 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1049767111 | 10497671 | Alopecia | |
| 1049767111 | 10497671 | Anaemia | |
| 1049767111 | 10497671 | Arthralgia | |
| 1049767111 | 10497671 | Bronchitis | |
| 1049767111 | 10497671 | Cough | |
| 1049767111 | 10497671 | Dehydration | |
| 1049767111 | 10497671 | Dyspepsia | |
| 1049767111 | 10497671 | Gastric disorder | |
| 1049767111 | 10497671 | Influenza | |
| 1049767111 | 10497671 | Nasopharyngitis | |
| 1049767111 | 10497671 | Oropharyngeal pain | |
| 1049767111 | 10497671 | Pain | |
| 1049767111 | 10497671 | Paraesthesia | |
| 1049767111 | 10497671 | Pleurisy | |
| 1049767111 | 10497671 | Pyrexia | |
| 1049767111 | 10497671 | Raynaud's phenomenon | |
| 1049767111 | 10497671 | Vitamin D decreased | |
| 1049767111 | 10497671 | Vomiting | |
| 1049767111 | 10497671 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1049767111 | 10497671 | 1 | 20130321 | 0 | ||
| 1049767111 | 10497671 | 2 | 201501 | 20150126 | 0 | |
| 1049767111 | 10497671 | 3 | 201501 | 20150128 | 0 | |
| 1049767111 | 10497671 | 4 | 2014 | 201501 | 0 | |
| 1049767111 | 10497671 | 6 | 2009 | 0 | ||
| 1049767111 | 10497671 | 7 | 2009 | 0 |